An analysis of more than 10,000 gliomas and clinical outcomes reported in Nature by scientists in Boston and Paris found that glioma patients whose tumors were hypermutated actually had no significant benefit when treated with checkpoint blockers.
- Faced with shortages, researchers combine heat and humidity to disinfect N95 masks
- 160 genes linked to brain shrinkage in study of 45,000 adults
- Ascorbic acid-mediated reactions in organic synthesis
- COVID-19 news from Annals of Internal Medicine
- Coldest Northern Hemisphere temperature, first recorded by UW, officially confirmed